Purchases and Sales Made in Q3 2023 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q3 2023. The information is specifically focused on institutions that hold shares of ARROWHEAD PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Thrivent Financial For Lutherans
Minneapolis, MN |
SELL
|
- |
-68.8K- 71.94% |
$1.8M - $2.48M
|
26.8K
$498K
|
|
|
Nov 06, 2023
Q3 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-77.4K- 15.55% |
$2.03M - $2.79M
|
420K
$7.79M
|
|
|
Nov 14, 2023
Q3 2023
|
Neuberger Berman Group LLC
New York, NY |
SELL
|
- |
-94.9K- 42.36% |
$2.49M - $3.42M
|
129K
$2.39M
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-97.8K- 3.4% |
$2.56M - $3.53M
|
2.78M
$51.6M
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-113K- 1.03% |
$2.97M - $4.09M
|
10.9M
$201M
|
|
|
Nov 14, 2023
Q3 2023
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-121K- 72.21% |
$3.16M - $4.35M
|
46.4K
$861K
|
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-159K- 44.6% |
$4.17M - $5.74M
|
198K
$3.67M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-192K- 29.98% |
$5.04M - $6.93M
|
449K
$8.32M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-193K- 64.24% |
$5.07M - $6.98M
|
108K
$2M
|
|
|
Nov 08, 2023
Q3 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-300K- 26.21% |
$7.86M - $10.8M
|
845K
$15.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-455K- 76.55% |
$11.9M - $16.4M
|
139K
$2.58M
|
|
|
Nov 14, 2023
Q3 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-478K- 94.19% |
$12.5M - $17.3M
|
29.5K
$547K
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-613K- 57.73% |
$16.1M - $22.1M
|
449K
$8.32M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-1.21MClosed |
$31.8M - $43.8M
|
0
$0
|